Filing Details

Accession Number:
0001104659-20-115702
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-16 17:38:20
Reporting Period:
2020-10-08
Accepted Time:
2020-10-16 17:38:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1609550 Inspire Medical Systems Inc. INSP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1199894 C Marilyn Nelson C/O Inspire Medical Systems, Inc.
5500 Wayzata Blvd., Suite 1600
Golden Valley MN 55416
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-13 5,500 $0.00 171,017 No 5 G Indirect See Footnote
Common Stock Disposition 2020-10-08 4,598 $129.20 166,419 No 4 S Indirect See Footnote
Common Stock Disposition 2020-10-08 7,979 $130.09 158,440 No 4 S Indirect See Footnote
Common Stock Disposition 2020-10-08 6,456 $131.05 151,984 No 4 S Indirect See Footnote
Common Stock Disposition 2020-10-08 2,633 $131.76 149,351 No 4 S Indirect See Footnote
Common Stock Disposition 2020-10-08 600 $132.77 148,751 No 4 S Indirect See Footnote
Common Stock Disposition 2020-10-08 200 $133.81 148,551 No 4 S Indirect See Footnote
Common Stock Disposition 2020-10-08 2,534 $135.17 146,017 No 4 S Indirect See Footnote
Common Stock Disposition 2020-10-09 1,000 $130.00 145,017 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,189 Direct
Footnotes
  1. Shares held by GDN Holdings, LLC, of which the Reporting Person is the managing member.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.51 to $129.50. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.54 to $130.53. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.54 to $131.52. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.58 to $132.11. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.66 to $132.98. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.80 to $133.82. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.16 to $135.20. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.